Xin Jin

Dr. Xin Jin

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2021 in Science
Verified
Journal Article
Closed access
PDF file
DGD. Dipon Ghosh
D. Dipon Ghosh
DLDongyeop Lee
Dongyeop Lee
XJXin Jin
Xin Jin
HHH. Robert Horvitz
H. Robert Horvitz
MNMichael N. Nitabach
Michael N. Nitabach
A new way to “see” color: Color perception is an important aspect of the way many organisms navigate their world. The ability to perceive color has thus far thought to depend on the presence of either eyes or minimally receptive cells containing opsin receptor genes. Ghosh et al. show that foraging Caenorhabditis elegans roundworms, which do not have eyes or opsins, can distinguish a blue color indicative of a toxin released by bacterial mats (see the Perspective by Neal and Vosshall). They suggest that the worms do this through the detection of the ratio between blue and amber light, a process dependent on at least two cellular stress-response genes. Different strains of C. elegans responded to different ratios, suggesting that this pathway plays an ecological role. Science , this issue p. 1059 ; see also p. 995

1 March 2021 in Molecular Therapy Nucleic Acids
Verified
Journal Article
Open access
XJXin Jin
Xin Jin
YXYuanyuan Xu
Yuanyuan Xu
MGMin Guo
Min Guo
YSYushuang Sun
Yushuang Sun
JDJunzhu Ding
Junzhu Ding
SLShanshan Li
Shanshan Li
In this study, we explored the circular RNA (circRNA) profile in pulmonary arterial hypertension (PAH) patients caused by chronic obstructive pulmonary disease (COPD) and the effects of hsa_circNFXL1_009 on abnormal proliferation, apoptosis, and migration of human pulmonary arterial smooth muscle cells (hPASMCs) driven by hypoxia. Using microarrays, we screened the circRNA profile in whole-blood samples from three pairs of subjects and found 158 dysregulated circRNAs in patients with PAH-COPD. Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) analysis further validated that hsa_circNFXL1_009 was dramatically downregulated with the highest area under a receiver operating characteristic curve (ROC) in 21 pairs of subjects. Consistently, exposure to hypoxia markedly reduced the hsa_circNFXL1_009 level in cultured hPASMCs. Delivery of exogenous hsa_circNFXL1_009 attenuated hypoxia-induced proliferation, apoptotic resistance, and migration of hPASMCs, as evidenced by immunocytochemistry, 5-ethynyl-2′-deoxyuridine incorporation, wound healing, and a TUNEL (terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling) assay. A luciferase assay showed that hsa_circNFXL1_009 directly sponged hsa-miR-29b-2-5p (miR-29b) and positively regulated the expression of voltage-gated potassium (K+) channel subfamily B member 1 (KCNB1) at the mRNA level. Using patch-clamp electrophysiology, we proved that overexpression of hsa_circNFXL1_009 promoted a whole-cell K+ current in hPASMCs. Taken together, these studies identify hsa_circNFXL1_009 as a key regulator of PAH, and it may be used as a potential therapeutic target for the treatment of PAH.

13 May 2022 in Cancer Letters
Verified
Journal Article
Open access
XZXiaomei Zhang
Xiaomei Zhang
XJXin Jin
Xin Jin
RSRui Sun
Rui Sun
MZMeng Zhang
Meng Zhang
WLWenyi Lu
Wenyi Lu
MZMingfeng Zhao
Mingfeng Zhao
Cellular immunotherapy has achieved incremental success in recent years. Varieties of cell products are undergoing fundamental research and clinical trials, among which CAR-T cell therapy is approved for marketing. As research progresses, these cells need to be modified to promote their safety and efficacy. Gene-editing technologies have evolved from RNA interference (RNAi), including small interfering RNAs (siRNAs) and short hairpin RNAs (shRNAs), to new generations of zinc finger nucleases (ZFNs), transcription-activator-like effector nucleases (TALENs), and clusters of regularly spaced short palindromic repeats (CRISPR/Cas9), and delivery methods are widely used. Here, we summarize the ongoing clinical trials and fundamental research for genome editing therapy. Additionally, we highlight existing in vivo delivery systems and their limitations to find a better method to deliver genes.

25 June 2024 in Brain Sciences
Verified
Journal Article
Open access
PDF file
XLXinxin Lv
Xinxin Lv
RZRuorui Zhang
Ruorui Zhang
SLShanshan Li
Shanshan Li
XJXin Jin
Xin Jin
Transfer RNAs (tRNAs) are well-known for their essential function in protein synthesis. Recent research has revealed a diverse range of chemical modifications that tRNAs undergo, which are crucial for various cellular processes. These modifications are necessary for the precise and efficient translation of proteins and also play important roles in gene expression regulation and cellular stress response. This review examines the role of tRNA modifications and dysregulation in the pathophysiology of various brain diseases, including epilepsy, stroke, neurodevelopmental disorders, brain tumors, Alzheimer’s disease, and Parkinson’s disease. Through a comprehensive analysis of existing research, our study aims to elucidate the intricate relationship between tRNA dysregulation and brain diseases. This underscores the critical need for ongoing exploration in this field and provides valuable insights that could facilitate the development of innovative diagnostic tools and therapeutic approaches, ultimately improving outcomes for individuals grappling with complex neurological conditions.

14 February 2023 in Pharmaceutical Biology
Verified
Journal Article
Open access
HYHou-Zhi Yang
Hou-Zhi Yang
RDRunbei Dong
Runbei Dong
YJYutao Jia
Yutao Jia
YLYuqiao Li
Yuqiao Li
GLGan Luo
Gan Luo
TSTianwei Sun
Tianwei Sun
Morroniside (MOR) possesses antiosteoporosis (OP) effects, but its molecular target and relevant mechanisms remain unknown.We investigated the effects of MOR on glucocorticoid-induced OP and osteob...

17 January 2022 in Cardiovascular Therapeutics
Verified
Journal Article
Open access
PDF file
SLShanshan Li
Shanshan Li
SLShuang Liang
Shuang Liang
YLYao Long
Yao Long
XCXu Chen
Xu Chen
XJXin Jin
Xin Jin
Pulmonary arterial hypertension (PAH) is characterized by abnormal remodeling of pulmonary vessel walls caused by excessive pulmonary arterial smooth muscle cell (PASMC) proliferation. Our previous clinical studies have demonstrated the importance of the downregulated circRNA in PAH. However, the role of upregulated circRNAs is still elusive. Here, we identified the upregulated circRNA in PAH patients, hsa_circWDR37_016 (circWDR37), as a key regulator of hypoxic proliferative disorder of pulmonary arterial smooth muscle cells (PASMCs). Quantitative real-time PCR (qRT-PCR) analysis validated that exposure to hypoxia markedly increased the circWDR37 level in cultured human PASMCs. As evidenced by flow cytometry, 5-ethynyl-2-deoxyuridine (EdU) incorporation, wound healing, and Tunel assay, silencing of endogenous circWDR37 attenuated proliferation and cell-cycle progression in hypoxia-exposed human PASMCs in vitro. Furthermore, bioinformatics and Luciferase assay showed that circWDR37 directly sponged hsa-miR-138-5p (miR-138) and was involved in the immunoregulatory and inflammatory processes of PAH. Together, these studies suggested new insights into circRNA regulated the pathology of PAH, providing a new potential therapeutic target for PAH treatment.